PeerView | Gastroenterology

Free CME from PeerView

Gastroenterology CME

Credits: 0.75 CME / NCPD / CPE / AAPA / IPCE

PVI, PeerView Institute for Medical Education

Elevating Outcomes for HER2-Expressing GI Cancers: The Evolving Role of Molecularly Targeted Agents in BTC and GEA Care

Josep Tabernero, MD, PhD / Shubham Pant, MD

November 28, 2023

Credits: 1.0 CME / MOC / AAPA

PVI, PeerView Institute for Medical Education

Revolutionizing Solid Tumor Treatment, Unleashing the Potential of Antibody–Drug Conjugates: How to Make the Most of the Latest Clinical Evidence to Enhance Patient Care

Paolo Tarantino, MD

November 14, 2023

Credits: 1.5 CME / NCPD / CE / CPE / AAPA

PVI, PeerView Institute for Medical Education

Antibody–Drug Conjugates, the Ultimate Weapons Against Solid Tumors: Latest Progress, Future Possibilities, and Implications for Patient Care

Beth Sandy, MSN, CRNP, FAPO

November 10, 2023

Credits: 1.0 CME / MOC / AAPA

PVI, PeerView Institute for Medical Education

Living With Eosinophilic Esophagitis: Recognizing the Burden on Patients and Integrating Targeted Therapy to Improve Outcomes

Seema S. Aceves, MD, PhD / Mirna Chehade, MD, MPH, AGAF, FAAAAI

October 06, 2023

Credits: 0.5 CME

PVI, PeerView Institute for Medical Education

Hope Is on the Horizon for Nonalcoholic Steatohepatitis: Leveraging the Power of Next Generation Monitoring and Pharmacotherapies

Rohit Loomba, MD, MHSc

July 03, 2023

Credits: 1.0 CME / MOC / CC / AAPA

PVI, PeerView Institute for Medical Education

Polishing Management Protocols in HER2-Expressing GI Cancers With Targeted Agents: A Focus on Refining Team-Based Strategies to Individualize BTC and GEA Care

Elena Elimova, MD, M.Sc., FRcPC

June 09, 2023

Credits: 1.5 CME / MOC / AAPA / IPCE

PVI, PeerView Institute for Medical Education

Renovating the Clinical Rulebook for HCC: Multidirectional Management With Innovative Immunotherapy and Targeted Platforms

Ghassan Abou-Alfa, MD, MBA

June 03, 2023

Credits: 1.0 CME / MOC

PVI, PeerView Institute for Medical Education

Taking Fuel From the IBD Fire: Applying New Evidence on Sphingosine-1-Phosphate Receptor Modulation as an Effective Oral Option for Management of Ulcerative Colitis

Miguel Regueiro, MD

May 09, 2023

Credits: 1.0 NCPD

Society of Gastroenterology Nurses and Associates (SGNA)

Addressing Unmet Nursing Needs in the Management of IBS-C: Understanding the Mechanism of Disease, Newer Therapies, and Coordinated Approaches to Treatment Barriers

Brooks D. Cash, MD, FACP, FACG, FASGE, AGAF, RFF / Kimberly Kearns, APRN, ANP-BC

April 18, 2023

Credits: 1.0 CME / MOC

PVI, PeerView Institute for Medical Education

HBV Is Primary! Your Role in the "Call to Action" to Eliminate Viral Hepatitis By 2030

Paul Kwo, MD, AGAF, FACG, FAASLD

March 22, 2023

Credits: 1.0 CME

The Medical College of Wisconsin

New Rules for VOD/SOS: Modern Risk Assessment, Diagnostic Principles, and Innovative Treatment

Prof. Mohamad Mohty / Christine N. Duncan, MD

March 13, 2023

Credits: 1.0 CME / CC

PVI, PeerView Institute for Medical Education

Refining Best Practices in Cancer Immunotherapy Biomarker Testing and Pathologic Response Assessment

Janis Taube, MD, MSc

March 02, 2023

Credits: 0.5 CME / MOC / NCPD / IPCE

PVI, PeerView Institute for Medical Education

What's New in the Management of Eosinophilic Esophagitis: Working Together to Integrate Targeted Treatment Options Into Practice

Evan S. Dellon, MD, MPH

February 21, 2023

Credits: 1.0 CME / MOC

PVI, PeerView Institute for Medical Education

Essential Conversations for HCC: Radiology-Oncology Collaboration and Immunotherapy Advances in Intermediate and Advanced Disease

Riad Salem, MD, MBA / Mark Yarchoan, MD

February 16, 2023

Credits: 1.5 CME / MOC

PVI, PeerView Institute for Medical Education

Getting Personal With Advanced BTC: Insights on Personalizing Upfront and Sequential Care With Immunotherapy and Targeted Agents

Rachna T. Shroff, MD, FASCO

January 21, 2023

Credits: 1.5 CME / MOC

PVI, PeerView Institute for Medical Education

Seek and You Will Find in Advanced GI Cancers: Identifying and Targeting Uncommon but Actionable Genomic Alterations in Colorectal, Pancreatic, and Other Cancers

Vivek Subbiah, MD

January 20, 2023

Credits: 1.5 CME / MOC

PVI, PeerView Institute for Medical Education

The HCC Revolution Continues: Exploring Evidence-Based Treatment Selection and Sequencing in Advanced Disease and Beyond

Ghassan Abou-Alfa, MD, MBA

January 20, 2023

Medical Learning Institute, Inc.

It Takes a Team for HCC: Improving Outcomes Through Multidisciplinary Collaboration & Modern Therapeutics

Amit Singal, MD, MS

November 05, 2022

PVI, PeerView Institute for Medical Education

The Latest on New Options for Eosinophilic Esophagitis: Considering Targeted Biologic Therapy

Arjan Bredenoord, Professor

October 26, 2022

PVI, PeerView Institute for Medical Education

Harnessing Novel Synergies With Tumor Treating Fields: Insights on Improving Survival With Multimodal Care in Aggressive Tumors

Erik P. Sulman, MD, PhD

October 24, 2022

PVI, PeerView Institute for Medical Education

Tools of the Trade: A Practical Guide to Managing NASH

Jay H. Shubrook, DO, FAAFP, FACOFP

October 17, 2022

PVI, PeerView Institute for Medical Education

Updates in Eosinophilic Esophagitis: Exploring Underlying Mechanisms and Integrating Novel Targeted Therapy to Improve Patient Care

Sandeep K. Gupta, MD

October 15, 2022

AGA Institute

An Exploration of Advances in the Diagnosis and Management of Irritable Bowel Syndrome and Chronic Idiopathic Constipation in a Unique Era of Patient Care: Incorporating an Individualized Approach to Help Your Patients Find Relief

Brooks D. Cash, MD, FACP, FACG, FASGE, AGAF, RFF

September 12, 2022

PVI, PeerView Institute for Medical Education

Uncovering Gene Fusions & Other Key Genomic Alterations in Lung, Thyroid, Colon, Breast, and Other Solid Tumors to Enable All Patients to Gain the Full Benefits of Targeted Treatment

Alexander Drilon, MD

August 16, 2022

Penn State College of Medicine

Moving the Treatment of Advanced Gastroesophageal Cancers Forward: How Can We Maximize the Benefits of Novel Immunotherapy Approaches?

Yelena Y. Janjigian, MD

July 15, 2022

PVI, PeerView Institute for Medical Education

Realizing Improved Outcomes in HER2-Positive Gastrointestinal Cancers: New Evidence and Practical Guidance With Targeted Agents

Elena Elez, MD, PhD

July 01, 2022

Medical Learning Institute, Inc.

Making Headway Towards Better Outcomes in Intermediate- to Advanced-Stage Hepatocellular Carcinoma: A Multidisciplinary Tumor Board on Implementing Novel Locoregional and Systemic Approaches

Riad Salem, MD, MBA

June 16, 2022

PVI, PeerView Institute for Medical Education

Setting the Course for the Optimal Management of HCC: Improving Patient Outcomes Through the Integration of Novel Therapeutic Approaches Across the Continuum of Care

Richard S. Finn, MD

June 05, 2022

PVI, PeerView Institute for Medical Education

Targeting TIGIT to Extend Immunotherapy Benefits to More Cancer Patients: A Strategy to Amplify Immune Response and Enhance or Restore Antitumor Activity

Zev A. Wainberg, MD

May 31, 2022

Penn State College of Medicine

Mapping the Therapeutic Odyssey in Multiple Myeloma: Interprofessional Guidance on Evidence-Based Treatment Selection and Sequencing

Nina Shah, MD

May 09, 2022

Free CME from PeerView

Gastroenterology CME

Pages

Upcoming Live Events

Education Collections

Recent CME Podcast